(Stroke. 2005;36:1910.)
© 2005 American Heart Association, Inc.
Original Contributions |
From Michigan Heart P.C. (H.D.A.), Ypsilanti, Michigan; and Cleveland Clinic Foundation (M.S., D.A.D., I.L.K., D.L.B., C.T.B., A.A.-C., K.W.D., P.L.W., J.S.Y.), Cleveland, Ohio.
Correspondence to Herbert D. Aronow, MD, MPH, Michigan Heart PC, 5325 Elliott Dr, Suite 203, Ypsilanti, MI 48197. E-mail haronow{at}michiganheart.com
Background and Purpose Protected stenting has emerged as a safe and effective alternative to endarterectomy for the treatment of carotid stenosis in patients at high operative risk. Distal microembolization occurs invariably during carotid stenting. Little is known about the relationship between systemic inflammation and embolization during carotid stenting.
Methods We examined 43 consecutive patients who underwent carotid stenting with simultaneous transcranial Doppler (TCD) monitoring of the ipsilateral middle cerebral artery. Embolization was quantified by measuring microembolic signals (MES) on TCD. Preprocedure leukocyte counts were related to MES.
Results In unadjusted analyses, preprocedure leukocyte count was positively correlated with total procedural MES (r2= 0.16; P=0.008). After considering age, gender, comorbidities, concomitant medical therapies, and the use of emboli prevention devices, increasing leukocyte count (ß=35 for each 1000/µL increment; P=0.018) remained a significant and independent predictor of embolization (model-adjusted r2=0.365; P=0.0005).
Conclusions Increasing preprocedure leukocyte count independently predicted more frequent MES during carotid stenting. These data suggest that systemic inflammation may influence the degree of procedural embolization.
Key Words: inflammation leukocytes stents
This article has been cited by other articles:
![]() |
M. Belkin and D. L. Bhatt Carotid Stenting in the Elderly: Is 80 the New 60? Circulation, May 5, 2009; 119(17): 2302 - 2304. [Full Text] [PDF] |
||||
![]() |
K. Groschel, U. Ernemann, J. Larsen, M. Knauth, F. Schmidt, J. Artschwager, and A. Kastrup Preprocedural C-Reactive Protein Levels Predict Stroke and Death in Patients Undergoing Carotid Stenting AJNR Am. J. Neuroradiol., October 1, 2007; 28(9): 1743 - 1746. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chaturvedi and J. S. Yadav The Role of Antiplatelet Therapy in Carotid Stenting for Ischemic Stroke Prevention Stroke, June 1, 2006; 37(6): 1572 - 1577. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |